(5R*,11R*)-5-Methyl-1,2-dihydro-5,11-methano-5H,11H-1,3-thiazolo[2,3-d][1,3,5]benzoxadiazocine
Authors:
Open Access
- 31 October 2009
- journal article
- other
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section E Structure Reports Online
- Vol. 65 (11) , o2967
Abstract
The title compound, C(13)H(14)N(2)OS, crystallizes as a racemate in a non-chiral space group. It represents a conformationally restricted analogue of so-called Biginelli compounds known to exhibit multiple pharmacological activities and was selected for a single-crystal X-ray analysis in order to probe the chemical and spatial requirements of some kinds of activity. It was found that the state of hybridization of the formally aminic nitro-gen of the heterocycle is between sp(2) and sp(3) with the lone-pair electrons partially delocalized through conjugation with the sulfur atom rather than the double bond of the pyrimidine nucleus. As a result, the thia-zolo ring adopts a flat-envelope conformation and the puckering of the central pyrimidine ring is close to a half-chair. The critical phenyl ring is fixed in a pseudo-axial and perpendicular [dihedral angle 84.6 (1)°] orientation with respect to the pyrimidine ring via an oxygen bridge.Keywords
This publication has 4 references indexed in Scilit:
- Structure validation in chemical crystallographyActa Crystallographica Section D Structural Biology, 2009
- A short history of SHELXActa Crystallographica Section A Foundations of Crystallography, 2007
- Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of NucleocapsidsScience, 2003
- Biologically active dihydropyrimidones of the Biginelli-type — a literature surveyEuropean Journal of Medicinal Chemistry, 2000